2

Condition A is that—

a

the prescription is issued in an EEA State other than the United Kingdom or Switzerland; and

b

the prescribing EEA health professional is legally entitled to issue a prescription of that kind in the EEA State in which the prescription is issued.

3

Condition B is that the prescription is signed in ink by the prescribing EEA health professional.

5

Condition D is that the prescription contains—

a

the patient’s—

i

surname,

ii

first names written out in full, and

iii

date of birth;

b

the issue date of the prescription;

c

the prescribing EEA health professional’s—

i

surname,

ii

first names written out in full,

iii

professional qualification,

iv

direct contact details including—

aa

email address, and

bb

telephone or fax number with the appropriate international prefix,

v

work address, and

vi

name of the relevant member State in which that EEA health professional works; and

d

details about the prescribed product, including where applicable the—

i

common name of the product,

ii

brand name if—

aa

the prescribed product is a biological medicinal product, or

bb

the prescribing EEA health professional deems it medically necessary for that product to be dispensed and the EEA health professional’s reasons justifying the use of the branded product,

iii

pharmaceutical formulation (tablet, solution, etc.),

iv

quantity,

v

strength of the medicinal product as defined in Article 1 of the 2001 Directive, and

vi

dosage regimen.